E-Book Content
HUMAN ANTIBODIES TO DENDRITIC CELLS GENERATION, ANALYSIS AND USE IN VACCINATION
HUMAN ANTIBODIES TO DENDRITIC CELLS GENERATION, ANALYSIS AND USE IN VACCINATION
HUMANE ANTILICHAMEN TEGEN DENDRITISCHE CELLEN Ontwikkeling, analyse en gebruik in vaccinatie
(met een samenvatting in het Nederlands)
PROEFSCHRIFT
ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de Rector Magnificus, Prof. dr. W.H. Gispen, ingevolge het besluit van het College voor Promoties in het openbaar te verdedigen op vrijdag 31 mei 2002 des middags te 2.30 uur
door
Annemarie Nicolette Lekkerkerker geboren op 6 december 1972, te Asse, België
Promotoren
Prof. dr. T. Logtenberg Prof. dr. H. Clevers
Cover: ‘Black Hollyhock with Blue Larkspur’ Georgia O’Keeffe 1929 ISBN: 90-393-3038-7
The studies described in this thesis were performed at the Department of Immunology, University Medical Center Utrecht, The Netherlands and were financially supported by Crucell N.V..
When you take a flower in your hand and really look at it, it’s your world for the moment. Georgia O’Keeffe
CONTENTS
CHAPTER 1 General introduction CHAPTER 2A Phage antibodies against human dendritic cell subpopulations by flow-cytometry based selection on freshly isolated cells CHAPTER 2B Phage antibodies selected on dendritic cells in human tonsil
9
33
51
CHAPTER 3 Reactivity profiles of human IgG4 monoclonal antibodies on naturally occurring and cultured dendritic cell subsets
69
CHAPTER 4 Binding and crosslinking of huMab MatDC 64 prevents the in vitro differentiation of human monocytes into dendritic cells
97
CHAPTER 5 In vitro antibody-mediated delivery of melanoma tumor antigen MAGE-1 to immature dendritic cells results in anti-tumor TH and CTL responses
111
CHAPTER 6 Lipid-tagged scFv fragments incorporated in tumor cells mediate receptor-dependent targeting to antigen presenting cells
131
CHAPTER 7 Summarizing discussion
145
Nederlandse Samenvatting
155
Curriculum Vitae
157
List of Publications
158
Nawoord
159
CHAPTER 1
GENERAL INTRODUCTION
GENERAL INTRODUCTION
INTRODUCTION The life cycle of dendritic cells Dendritic cells (DCs), first described in 1973 by Steinman and Cohn 1, are now widely recognized as professional antigen presenting cells (APCs) that play a pivotal role in directing the immune response. The ability of DCs to process and present a broad variety of antigens, to which an organism is exposed, is unmatched. The functioning of the immune system is based on two distinct types of responses, the innate and the adaptive immune response. The innate immune response, mediated by a variety of cell types including natural killer (NK) cells and macrophages, forms the first line of defense towards infections and is regarded as non-specific. The adaptive immune response depends on the activity of antigen-specific effector T and B cells and is notable for its exquisite specificity for the inciting antigen and the generation of memory for antigens. DCs are innate immune cells and acutely activated when a pathogen invades the body, but they also play a decisive and instructive role in the adaptive immune response that arises 2. Given that the induction of productive T cell responses depends upon activation of DCs, it follows that the DC serves as a pivotal interface bridging the innate and adaptive immune system. Generated in large numbers in the bone marrow every day, precursor DCs circulate in the blood stream and migrate into tissues, where they reside as sentinels in an immature state, the prototype being Langerhans cells in the epidermis. Immat